By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy and Cookie Policy for more information.
2022 NICE - National Institute for Health and Care Excellence
Abstract
Abstract
“The MiraQ system is recommended as a cost saving option for assessing graft flow during coronary artery bypass graft surgery. Clinical evidence shows that the MiraQ system is effective for assessing coronary artery bypass grafts and allows for grafts to be revised during surgery.
This may reduce the frequency of graft occlusion and may reduce perioperative morbidity and mortality.
The MiraQ system can lead to an estimated cost saving of £80.27 per person compared with clinical assessment.”
.svg)
